Duncan Greenhalgh
Goodwin Procter - UNITED STATES
Duncan Greenhalgh's competencies
| Practice Area | Jurisdiction | Rank | Agg. Deals Value | Clients Dimension | N. of Transactions | Last Quarter |
|---|---|---|---|---|---|---|
| IP&IT | UNITED STATES | 123 | 3135 | 1321 | 6 |  |
| Life Science & Health Care | UNITED STATES | 84 | 1500 | 25 | 1 |  |
| Practice Area | Jurisdiction | Rank | Agg. Deals Value | Clients Dimension | N. of Transactions | Last Quarter |
Showing 1 to 2 of 2 entries
Client Reviews
The Client Reviews provides a qualitative rating based on Partners' Clients feedback assessmentCommunication Skills
Technical skills
Efficiency
Effectiveness
Perceived Added Value
Ranking 2022: Duncan Greenhalgh - Goodwin Procter
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
|---|---|---|---|---|
| IP&IT | 3100 | 1580 | 5 |  |
| Life Science & Health Care | 1500 | 25 | 1 |  |
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
Showing 1 to 2 of 2 entries
Ranking 2021: Duncan Greenhalgh - Goodwin Procter
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
|---|---|---|---|---|
| Corporate M&A | 95 | 25 | 1 |  |
| IP&IT | 2065 | 4448 | 7 |  |
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
Ranking 2020: Duncan Greenhalgh - Goodwin Procter
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
|---|---|---|---|---|
| IP&IT | 430 | 3325 | 4 |  |
| Practice Area | Agg. Deals Value | Clients Dimension | N. of Transactions | Tier |
Significant Clients
The chart shows a balanced list of the Duncan Greenhalgh's client portfolio - based on PBV Monitor's Analyzed Transactions during last Twelve MounthsTeam
The chart shows a balanced list of counselor working with Duncan Greenhalgh - based on PBV Monitor's analyzed transactions during last Twelve MounthsCo-Counsel
The Chart shows a balanced list of Duncan Greenhalgh's Co-Counsel Law Firm - based on PBV Monitor's analyzed transactions during last Twelve MounthsCounterparts
The Chart shows a balanced list of Duncan Greenhalgh's other Firms involved - based on PBV Monitor's analyzed transactions during last Twelve MounthsPeer Reviews
The Peer Reviews provides a qualitative rating based on Counterparts / Referees' feedback assessmentRecent experiences
MBX Biosciences' $187.7 Million IPO9/23/2024